Metabolic syndrome: focus on dyslipidemia (Q36461906)

14 August 2017

1 reference

title

Metabolic syndrome: focus on dyslipidemia (English)

1 reference

14 August 2017

1 reference

1 reference

Henry N Ginsberg

1

1 reference

PubMed ID

16642962

14 August 2017

Yuan-Li Zhang

series ordinal

2

1 reference

PubMed ID

16642962

14 August 2017

Antonio Hernandez-Ono

series ordinal

3

1 reference

14 August 2017

1 February 2006

1 reference

14 August 2017

1 reference

14 August 2017

14 Suppl 1

1 reference

14 August 2017

41S-49S

1 reference

Role of Insulin in Endogenous Hypertriglyceridemia*

14 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Obesity-induced inflammatory changes in adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Increasing prevalence of the metabolic syndrome among u.s. Adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Banting lecture 1988. Role of insulin resistance in human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

INTERRELATIONSHIP BETWEEN SKINFOLD THICKNESS, SERUM LIPIDS AND BLOOD SUGAR IN NORMAL MEN

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Subclinical states of glucose intolerance and risk of death in the U.S.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Cardiovascular morbidity and mortality associated with the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Intracellular assembly of VLDL: two major steps in separate cell compartments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Microsomal triglyceride transfer protein: a multifunctional protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Insulin resistance and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Precursors of plasma triglyceride fatty acids in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Regulation of hepatic apolipoprotein B-lipoprotein assembly and secretion by the availability of fatty acids. I. Differential response to the delivery of fatty acids via albumin or remnant-like emulsion particles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Post-transcriptional stimulation of the assembly and secretion of triglyceride-rich apolipoprotein B lipoproteins in a mouse with selective deficiency of brown adipose tissue, obesity, and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed ham

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Systemic and regional free fatty acid metabolism in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

The hormone resistin links obesity to diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Adiponectin: systemic contributor to insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

De novo lipogenesis in humans: metabolic and regulatory aspects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Association between inflammation and insulin resistance in U.S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Adipose tissue as an endocrine organ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

Interleukin-6 stimulates hepatic triglyceride secretion in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.281

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.281

1 reference

14 August 2017

1 reference

PubMed ID

16642962